Effekte von Orlistat auf die Insulinsensitivität und den intramyozellulären Lipidgehalt bei insulinresistenten nicht-diabetischen Personen, unabhängig von der Gewichtsabnahme

作者: Matthias Bernhard Dirr

DOI:

关键词: Medicine

摘要:

参考文章(80)
R C Bonadonna, R A De Fronzo, Glucose metabolism in obesity and type 2 diabetes Diabète & métabolisme. ,vol. 17, pp. 112- 135 ,(1991)
J J Robert, Methods for the measurement of insulin resistance. Hyperinsulinemic euglycemic clamp Presse Medicale. ,vol. 24, pp. 730- 734 ,(1995)
John C. Pickup, Gareth Williams, Textbook of Diabetes ,(1991)
Ruth B. S. Harris, Helen Kor, Insulin insensitivity is rapidly reversed in rats by reducing dietary fat from 40 to 30% of energy. Journal of Nutrition. ,vol. 122, pp. 1811- 1822 ,(1992) , 10.1093/JN/122.9.1811
G. M. Reaven, Pathophysiology of insulin resistance in human disease Physiological Reviews. ,vol. 75, pp. 473- 486 ,(1995) , 10.1152/PHYSREV.1995.75.3.473
E J Mayer-Davis, J H Monaco, H M Hoen, S Carmichael, M Z Vitolins, M J Rewers, S M Haffner, M F Ayad, R N Bergman, A J Karter, Dietary fat and insulin sensitivity in a triethnic population: the role of obesity. The Insulin Resistance Atherosclerosis Study (IRAS) The American Journal of Clinical Nutrition. ,vol. 65, pp. 79- 87 ,(1997) , 10.1093/AJCN/65.1.79
SUSAN P. HELMRICH, DAVID R. RAGLAND, RALPH S. PAFFENBARGER, Prevention of non-insulin-dependent diabetes mellitus with physical activity. Medicine and Science in Sports and Exercise. ,vol. 26, pp. 824- 830 ,(1994) , 10.1249/00005768-199407000-00003
Steven B. Heymsfield, Karen R. Segal, Jonathan Hauptman, Charles P. Lucas, Mark N. Boldrin, Aila Rissanen, John P. H. Wilding, Lars Sjöström, Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults. JAMA Internal Medicine. ,vol. 160, pp. 1321- 1326 ,(2000) , 10.1001/ARCHINTE.160.9.1321
OliverP. Bachmann, DominikB. Dahl, Klaus Brechtel, Juergen Machann, Mette Nielsen, Fritz Schick, Julian Platon, HansU. Häring, Stephan Jacob, Orlistat (Xenical®) improves insulin sensitivity (IS) in obese intentionally weight maintaining subjects Diabetes Research and Clinical Practice. ,vol. 50, pp. 70- ,(2000) , 10.1016/S0168-8227(00)81692-7